Prime Capital Investment Advisors’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $824K | Buy |
|
|||||
|
2025
Q1 | $585K | Buy |
|
|||||
|
2024
Q4 | $506K | Sell |
|
|||||
|
2024
Q3 | $565K | Sell |
|
|||||
|
2024
Q2 | $565K | Sell |
|
|||||
|
2024
Q1 | $733K | Buy |
|
|||||
|
2023
Q4 | $577K | Buy |
|
|||||
|
2023
Q3 | $309K | Buy |
|
|||||
|
2023
Q2 | $334K | Buy |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $655K | Buy |
|
|||||
|
2022
Q3 | $214K | Buy |
|